Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
57.70
-0.21 (-0.36%)
At close: Apr 16, 2026, 4:00 PM EDT
57.70
0.00 (0.00%)
After-hours: Apr 16, 2026, 5:17 PM EDT
Monopar Therapeutics Analyst Ratings
Total Analysts
11
Consensus Rating
Strong Buy
Price Target
$107.00
Upside
+85.44%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Strong Buy Maintains $100 | Strong Buy | Maintains | $100 | +73.31% | Mar 30, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $104 | Strong Buy | Reiterates | $104 | +80.24% | Feb 23, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $104 | Strong Buy | Reiterates | $104 | +80.24% | Feb 2, 2026 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $100 | Strong Buy | Maintains | $100 | +73.31% | Jan 29, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $104 | Strong Buy | Reiterates | $104 | +80.24% | Jan 14, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $115 | Buy | Initiates | $115 | +99.31% | Jan 9, 2026 |
| Raymond James | Raymond James | Strong Buy → Buy Downgrades $142 → $123 | Strong Buy → Buy | Downgrades | $142 → $123 | +113.17% | Nov 14, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $100 | Strong Buy | Maintains | $100 | +73.31% | Nov 13, 2025 |
| Leerink Partners | Leerink Partners | Buy Initiates $115 | Buy | Initiates | $115 | +99.31% | Nov 10, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $85 → $100 | Strong Buy | Maintains | $85 → $100 | +73.31% | Nov 9, 2025 |
| Barclays | Barclays | Buy Initiates $125 | Buy | Initiates | $125 | +116.64% | Oct 13, 2025 |
| Raymond James | Raymond James | Strong Buy Maintains $80 → $142 | Strong Buy | Maintains | $80 → $142 | +146.10% | Oct 6, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $77 → $115 | Buy | Maintains | $77 → $115 | +99.31% | Oct 2, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $70 → $105 | Strong Buy | Maintains | $70 → $105 | +81.98% | Sep 29, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $76 → $95 | Buy | Maintains | $76 → $95 | +64.64% | Sep 25, 2025 |
| BTIG | BTIG | Strong Buy Maintains $87 → $104 | Strong Buy | Maintains | $87 → $104 | +80.24% | Sep 25, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.